Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab
Team effort: Naomi Petela, Thomas Gligoris and Johanna Scheinost from the Nasmyth lab

Malarial proteinA new study fills in the gaps in our understanding of a protein complex that traps DNA during cell division until the critical moment just before the daughter cells separate. The researchers behind the work, from Kim Nasmyth's lab in the Department of Biochemistry and the lab of Jan we at the MRC LMB in Cambridge, describe their findings in a recent paper in Science (1). Using new structural information about how the individual components of the cohesin complex fit together, the group has confirmed in living cells what has been suspected to be the case - that the complex adopts a ring structure that holds the two arms of the chromosome together until exactly the right moment in cell division. Researchers can now begin to probe the mechanisms behind cohesin's functions.

Read more (Department of Biochemistry website)

Image: Newly solved crystal structure of part of the cohesin complex

  1. 'Closing the cohesin ring: structure and function of its Smc3-kleisin interface.' Gligoris, TG, Scheinost, JC, Burmann, F, Petela, N, Chan, K-L, Uluocak, P, Beckouet, F, Gruber, S, Nasmyth, K and Lowe, J. Science (2014) Vol. 346 no. 6212 p963-967.

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.